IMPL

IMPEL PHARMACEUTICALS INCCIK 1445499 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for IMPL PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for IMPL

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Vivo Capital Surplus Fund VIII, L.P.	10% Owner	30	$8.63M	$74.1K	2023-12-19
Oaktree AZ Strategic Lending Fund, L.P.	10% Owner	1	$0	$0	2023-11-30
Oaktree Specialty Lending Corp	10% Owner	1	$0	$0	2023-11-30
BROOKFIELD Corp /ON/	10% Owner	1	$0	$0	2023-11-30
Allison David D.	Director	3	$0	$0	2023-06-16
Cline Darren S	Director	2	$0	$0	2023-06-16
Wilfong Diane E.	Director	3	$0	$0	2023-06-16
SHAH MAHENDRA	Director	3	$0	$0	2023-06-16
NELSON TIMOTHY S	Director	4	$107.6K	$0	2023-06-16
Kalb Michael Wayne	CFO	2	$0	$0	2023-05-10
Hoekman John	Chief Scientific Officer	12	$0	$0	2023-02-14
Paolillo Leonard	Chief Commercial Officer	3	$0	$0	2023-02-14
Leaman John Harold	Chief Financial Officer	7	$0	$0	2023-02-14
ADAMS ADRIAN	COB, CEO and President	6	$279.9K	$0	2023-02-14
PARKER H STEWART	Director	17	$0	$0	2022-06-16
SHREWSBURY STEPHEN B	Chief Medical Officer	10	$0	$0	2022-03-29
Kossow Jon Erik	10% Owner	5	$12.38M	$0	2021-04-27
PARMAR KUSH	10% Owner	11	$8.63M	$0	2021-04-27
venBio Global Strategic Fund II L.P.	10% Owner	8	$6.75M	$0	2021-04-27
KRAVIS HENRY R	10% Owner	4	$16.50M	$0	2021-04-27
ROCKLAGE SCOTT M	10% Owner	1	$0	$0	2021-04-22
HAQUE PROMOD	10% Owner	1	$0	$0	2021-04-22

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Vivo Capital Surplus Fund VIII	10% Owner	S Sale	2023-12-19	2023-12-19	208,657	$0.08	$16.7K	2,029,495	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	S Sale	2023-12-19	2023-12-19	28,632	$0.08	$2.3K	280,294	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	S Sale	2023-12-18	2023-12-19	28,682	$0.11	$3.2K	308,926	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	S Sale	2023-12-18	2023-12-19	209,029	$0.11	$23.0K	2,238,152	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	S Sale	2023-12-15	2023-12-19	87,934	$0.29	$25.5K	2,447,181	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	S Sale	2023-12-15	2023-12-19	12,066	$0.29	$3.5K	337,608	SEC↗
Oaktree Specialty Lending Corp	10% Owner	J Other deriv	2023-11-30	2023-12-04	445,294	—	$0	3,117,057	SEC↗
Oaktree AZ Strategic Lending F	10% Owner	J Other deriv	2023-11-30	2023-12-04	445,294	—	$0	3,117,057	SEC↗
BROOKFIELD Corp /ON/	10% Owner	J Other deriv	2023-11-30	2023-12-04	445,294	—	$0	3,117,057	SEC↗
Allison David D.	Director	A Award deriv	2023-06-16	2023-06-20	13,222	—	$0	13,222	SEC↗
NELSON TIMOTHY S	Director	A Award deriv	2023-06-16	2023-06-20	13,222	—	$0	13,222	SEC↗
SHAH MAHENDRA	Director	A Award deriv	2023-06-16	2023-06-20	13,222	—	$0	13,222	SEC↗
Wilfong Diane E.	Director	A Award deriv	2023-06-16	2023-06-20	13,222	—	$0	13,222	SEC↗
Cline Darren S	Director	A Award deriv	2023-06-16	2023-06-20	13,222	—	$0	13,222	SEC↗
Kalb Michael Wayne	CFO	A Award deriv	2023-05-10	2023-05-12	175,000	—	$0	175,000	SEC↗
Kalb Michael Wayne	CFO	A Award deriv	2023-05-10	2023-05-12	47,500	—	$0	47,500	SEC↗
Cline Darren S	Director	A Award deriv	2023-04-12	2023-04-14	20,013	—	$0	20,013	SEC↗
ADAMS ADRIAN	COB, CEO and President	A Award deriv	2023-02-14	2023-02-16	200,000	—	$0	200,000	SEC↗
Leaman John Harold	Chief Fin. & Business Office	A Award deriv	2023-02-14	2023-02-16	70,000	—	$0	70,000	SEC↗
Hoekman John	Chief Scientific Officer	A Award deriv	2023-02-14	2023-02-16	42,500	—	$0	42,500	SEC↗
Paolillo Leonard	Chief Commercial Officer	A Award deriv	2023-02-14	2023-02-16	50,000	—	$0	50,000	SEC↗
Leaman John Harold	Chief Fin. & Business Office	M Exercise deriv	2022-12-31	2023-01-04	10,571	—	$0	0	SEC↗
Leaman John Harold	Chief Fin. & Business Office	F Tax w/h	2022-12-31	2023-01-04	3,627	$3.75	$13.6K	6,944	SEC↗
Leaman John Harold	Chief Fin. & Business Office	M Exercise	2022-12-31	2023-01-04	10,571	—	$0	10,571	SEC↗
Allison David D.	Director	A Award deriv	2022-06-16	2022-06-17	12,789	—	$0	12,789	SEC↗
PARKER H STEWART	Director	A Award deriv	2022-06-16	2022-06-17	12,789	—	$0	12,789	SEC↗
NELSON TIMOTHY S	Director	A Award deriv	2022-06-16	2022-06-17	12,789	—	$0	12,789	SEC↗
SHAH MAHENDRA	Director	A Award deriv	2022-06-16	2022-06-17	12,789	—	$0	12,789	SEC↗
Wilfong Diane E.	Director	A Award deriv	2022-06-16	2022-06-17	12,789	—	$0	12,789	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	M Exercise deriv	2022-03-29	2022-03-30	24,606	—	$0	0	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	M Exercise	2022-03-29	2022-03-30	24,606	$1.97	$48.5K	97,990	SEC↗
ADAMS ADRIAN	COB, CEO and President	A Award deriv	2022-01-26	2022-01-28	175,000	—	$0	175,000	SEC↗
Hoekman John	Chief Scientific Officer	A Award deriv	2022-01-26	2022-01-28	35,000	—	$0	35,000	SEC↗
Leaman John Harold	Chief Fin. & Business Office	A Award deriv	2022-01-26	2022-01-28	100,000	—	$0	100,000	SEC↗
Paolillo Leonard	Chief Commercial Officer	A Award deriv	2022-01-26	2022-01-28	40,000	—	$0	40,000	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	A Award deriv	2022-01-26	2022-01-28	30,000	—	$0	30,000	SEC↗
Hoekman John	Chief Scientific Officer	M Exercise deriv	2021-12-22	2021-12-23	20,000	—	$0	0	SEC↗
Hoekman John	Chief Scientific Officer	M Exercise	2021-12-22	2021-12-23	20,000	$1.64	$32.8K	128,221	SEC↗
NELSON TIMOTHY S	Director	P Buy	2021-11-19	2021-11-22	10,000	$10.76	$107.6K	10,000	SEC↗
Leaman John Harold	Chief Fin. & Business Office	A Award deriv	2021-10-19	2021-10-21	10,571	—	$0	10,571	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	M Exercise deriv	2021-09-21	2021-09-22	14,780	—	$0	0	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	M Exercise deriv	2021-09-21	2021-09-22	4,650	—	$0	541	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	M Exercise deriv	2021-09-21	2021-09-22	53,954	—	$0	29,587	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	M Exercise	2021-09-21	2021-09-22	14,780	$1.97	$29.1K	14,780	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	M Exercise	2021-09-21	2021-09-22	4,650	$2.46	$11.4K	19,430	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	M Exercise	2021-09-21	2021-09-22	53,954	$2.95	$159.2K	73,384	SEC↗
ADAMS ADRIAN	COB, CEO and President	P Buy	2021-08-18	2021-08-19	600	$15.89	$9.5K	20,000	SEC↗
ADAMS ADRIAN	COB, CEO and President	P Buy	2021-08-18	2021-08-19	2,197	$14.91	$32.8K	19,400	SEC↗
ADAMS ADRIAN	COB, CEO and President	P Buy	2021-08-18	2021-08-19	17,203	$13.81	$237.6K	17,203	SEC↗
ADAMS ADRIAN	COB, CEO and President	A Award deriv	2021-07-20	2021-07-26	50,000	—	$0	50,000	SEC↗
Hoekman John	Chief Scientific Officer	A Award deriv	2021-07-20	2021-07-26	50,000	—	$0	50,000	SEC↗
Leaman John Harold	Chief Financial Officer	A Award deriv	2021-07-20	2021-07-26	50,000	—	$0	50,000	SEC↗
Paolillo Leonard	Chief Commercial Officer	A Award deriv	2021-07-20	2021-07-26	30,000	—	$0	30,000	SEC↗
SHREWSBURY STEPHEN B	Chief Medical Officer	A Award deriv	2021-07-20	2021-07-26	50,000	—	$0	50,000	SEC↗
Allison David D.	Director	A Award deriv	2021-07-11	2021-07-13	11,500	—	$0	11,500	SEC↗
NELSON TIMOTHY S	Director	A Award deriv	2021-07-11	2021-07-13	11,500	—	$0	11,500	SEC↗
PARKER H STEWART	Director	A Award deriv	2021-07-11	2021-07-13	11,500	—	$0	11,500	SEC↗
SHAH MAHENDRA	Director	A Award deriv	2021-07-11	2021-07-13	11,500	—	$0	11,500	SEC↗
Wilfong Diane E.	Director	A Award deriv	2021-07-11	2021-07-13	11,500	—	$0	11,500	SEC↗
KRAVIS HENRY R	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	42,307,448	—	$0	0	SEC↗
Hoekman John	Chief Scientific Officer	C Conversion deriv	2021-04-27	2021-04-29	69,657	—	$0	0	SEC↗
Hoekman John	Chief Scientific Officer	X Exercise deriv	2021-04-27	2021-04-29	8,523	$8.19	$69.8K	0	SEC↗
Hoekman John	Chief Scientific Officer	X Exercise deriv	2021-04-27	2021-04-29	8,523	—	$0	69,657	SEC↗
PARKER H STEWART	Director	C Conversion deriv	2021-04-27	2021-04-29	0	—	$0	0	SEC↗
PARKER H STEWART	Director	C Conversion deriv	2021-04-27	2021-04-29	143,986	—	$0	0	SEC↗
PARKER H STEWART	Director	X Exercise deriv	2021-04-27	2021-04-29	47,236	—	$0	143,986	SEC↗
PARKER H STEWART	Director	X Exercise deriv	2021-04-27	2021-04-29	47,263	$8.66	$409.3K	0	SEC↗
PARKER H STEWART	Director	C Conversion deriv	2021-04-27	2021-04-29	120,447	—	$0	0	SEC↗
PARKER H STEWART	Director	X Exercise deriv	2021-04-27	2021-04-29	13,756	—	$0	120,447	SEC↗
PARKER H STEWART	Director	X Exercise deriv	2021-04-27	2021-04-29	13,756	$8.19	$112.7K	0	SEC↗
PARKER H STEWART	Director	C Conversion deriv	2021-04-27	2021-04-29	61,109	—	$0	0	SEC↗
venBio Global Strategic Fund I	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	8,845,942	—	$0	0	SEC↗
venBio Global Strategic Fund I	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	8,201,930	—	$0	0	SEC↗
venBio Global Strategic Fund I	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	13,233,885	—	$0	0	SEC↗
venBio Global Strategic Fund I	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	0	—	$0	0	SEC↗
venBio Global Strategic Fund I	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	5,876,034	—	$0	0	SEC↗
Kossow Jon Erik	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	35,256,206	—	$0	0	SEC↗
Kossow Jon Erik	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	0	—	$0	0	SEC↗
PARMAR KUSH	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	5,876,034	—	$0	0	SEC↗
PARMAR KUSH	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	13,233,885	—	$0	0	SEC↗
PARMAR KUSH	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	8,845,942	—	$0	0	SEC↗
PARMAR KUSH	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	8,201,930	—	$0	0	SEC↗
PARMAR KUSH	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	1,359,799	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	11,628,174	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	5,162,969	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	995,714	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	7,206,216	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	713,064	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	0	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	0	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	1,073,308	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	7,772,634	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion deriv	2021-04-27	2021-04-29	1,605,711	—	$0	0	SEC↗
Hoekman John	Chief Scientific Officer	C Conversion deriv	2021-04-27	2021-06-07	69,657	—	$0	0	SEC↗
KRAVIS HENRY R	10% Owner	P Buy	2021-04-27	2021-04-29	1,100,000	$15.00	$16.50M	3,802,638	SEC↗
KRAVIS HENRY R	10% Owner	C Conversion	2021-04-27	2021-04-29	2,583,926	—	$0	2,583,926	SEC↗
KRAVIS HENRY R	10% Owner	J Other	2021-04-27	2021-04-29	118,712	$13.50	$1.60M	2,702,638	SEC↗
Hoekman John	Chief Scientific Officer	C Conversion	2021-04-27	2021-04-29	4,523	—	$0	108,496	SEC↗
Hoekman John	Chief Scientific Officer	J Other	2021-04-27	2021-04-29	275	—	$0	108,221	SEC↗
PARKER H STEWART	Director	J Other	2021-04-27	2021-04-29	1,666	—	$0	17,756	SEC↗
PARKER H STEWART	Director	C Conversion	2021-04-27	2021-04-29	271	$13.50	$3.7K	18,027	SEC↗
PARKER H STEWART	Director	C Conversion	2021-04-27	2021-04-29	8,793	—	$0	19,422	SEC↗
PARKER H STEWART	Director	J Other	2021-04-27	2021-04-29	458	—	$0	10,629	SEC↗
PARKER H STEWART	Director	C Conversion	2021-04-27	2021-04-29	7,355	—	$0	11,087	SEC↗
PARKER H STEWART	Director	C Conversion	2021-04-27	2021-04-29	3,732	—	$0	3,732	SEC↗
venBio Global Strategic Fund I	10% Owner	C Conversion	2021-04-27	2021-04-29	2,309,791	—	$0	2,309,791	SEC↗
venBio Global Strategic Fund I	10% Owner	P Buy	2021-04-27	2021-04-29	450,000	$15.00	$6.75M	2,759,791	SEC↗
Kossow Jon Erik	10% Owner	C Conversion	2021-04-27	2021-04-29	2,153,271	—	$0	2,252,198	SEC↗
Kossow Jon Erik	10% Owner	P Buy	2021-04-27	2021-04-29	825,000	$15.00	$12.38M	3,077,198	SEC↗
Kossow Jon Erik	10% Owner	C Conversion	2021-04-27	2021-04-29	98,927	$13.50	$1.34M	98,927	SEC↗
PARMAR KUSH	10% Owner	C Conversion	2021-04-27	2021-04-29	358,878	—	$0	2,208,334	SEC↗
PARMAR KUSH	10% Owner	P Buy	2021-04-27	2021-04-29	575,000	$15.00	$8.63M	575,000	SEC↗
PARMAR KUSH	10% Owner	C Conversion	2021-04-27	2021-04-29	101,457	$13.50	$1.37M	2,309,791	SEC↗
PARMAR KUSH	10% Owner	C Conversion	2021-04-27	2021-04-29	500,932	—	$0	1,849,456	SEC↗
PARMAR KUSH	10% Owner	C Conversion	2021-04-27	2021-04-29	540,265	—	$0	1,348,524	SEC↗
PARMAR KUSH	10% Owner	C Conversion	2021-04-27	2021-04-29	808,259	—	$0	808,259	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	P Buy	2021-04-27	2021-04-29	69,380	$15.00	$1.04M	349,674	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	P Buy	2021-04-27	2021-04-29	505,620	$15.00	$7.58M	2,535,115	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	12,311	$13.50	$166.2K	280,294	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	89,145	$13.50	$1.20M	2,029,495	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	43,550	—	$0	267,983	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	315,328	—	$0	1,940,350	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	60,813	—	$0	224,433	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	440,119	—	$0	1,625,022	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	65,552	—	$0	163,620	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	474,713	—	$0	1,184,903	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	98,068	—	$0	98,068	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	C Conversion	2021-04-27	2021-04-29	710,190	—	$0	710,190	SEC↗
Hoekman John	Chief Scientific Officer	C Conversion	2021-04-27	2021-06-07	4,253	—	$0	108,496	SEC↗
ROCKLAGE SCOTT M	10% Owner	J Other deriv	2021-04-22	2021-04-26	1,359,799	—	$0	1,359,799	SEC↗
PARKER H STEWART	Director	J Other deriv	2021-04-22	2021-04-26	0	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	J Other deriv	2021-04-22	2021-04-26	0	—	$0	0	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	J Other deriv	2021-04-22	2021-04-26	0	—	$0	0	SEC↗
HAQUE PROMOD	10% Owner	J Other deriv	2021-04-22	2021-04-26	0	—	$0	0	SEC↗
venBio Global Strategic Fund I	10% Owner	J Other deriv	2021-04-22	2021-04-26	0	—	$0	0	SEC↗